Schedule your COVID-19 vaccine wherever possible. Please do not call your doctor as they cannot schedule an appointment for you. Learn more.

Clinical Advances in the Diagnosis and Management of Pulmonary Hypertension

About This Activity

Program Overview

This continuing education activity covers all forms of pulmonary hypertension. Expert faculty discuss the epidemiology of PH, how PH is diagnosed, and the poor outcomes associated with PH when left untreated. Participants will be left with a better understanding of the difference between PAH and PVH and why the difference matters. Therapies for PAH and PVH will also be discussed with reference to current clinical guidelines.


Educational Objectives

After completing this internet enduring material, participants should be able to:

  • Describe the epidemiology and pathophysiology of pulmonary hypertension.
  • Determine who is at risk for pulmonary hypertension and effectively diagnose patients.
  • Recognize the difference between PAH and PVH and how this translates into therapy.
  • Outline the current approach to pulmonary hypertension treatment in the presence of related or underlying diseases.
  • Evaluate current pharmacologic and medical management strategies for patients with pulmonary hypertension.
  • Incorporate novel therapies into patient care for improved outcomes.
  • Identify when to refer patients for specialty treatment.

Agenda

Pulmonary Hypertension: The Hidden Killer

J. Thomas Heywood, MD


Pulmonary Arterial Hypertension: It’s the Lungs

Rajeev C. Mohan, MD


Pulmonary Venous Hypertension: Common and Overlooked

Ajay V. Srivastava, MD


Rheumatic Disease and Pulmonary Disease: Pearls and Tips

Richard M. Keating, MD


Blood Clots and Pulmonary Hypertension: When to Call the Surgeon

Demosthenes Papamatheakis, MD


Pulmonary Arterial Hypertension in Chronic Lung Disease: Diagnosis and Management

Kelly Fan, MD


Adult Congenital Heart Disease: More Common Than You Think!

Laith Alshawabkeh, MD


Pulmonary Hypertension: Putting it All Together

Five Things You Should Know After this Conference

J. Thomas Heywood, MD

Enduring Material Details

Released On

April 7, 2021


Expires On

October 7, 2021


Media Type

Internet Enduring Material


Completion Time

4 hours


Credit Available

4 AMA PRA Category 1 Credit(s)™


Target Audience

This activity is intended for physicians and other health care practitioners treating patients with various types of pulmonary hypertension.

Disclosure Policy

In accordance with the ACCME Standards for Commercial Support, course directors, planning committees, faculty and all others in control of the educational content of the CME activity must disclose all relevant financial relationships with any commercial interest that they may have had within the past 12 months. If an individual refuses to disclose relevant financial relationships, they will be disqualified from being a part of the planning and implementation of this CME activity. Owners and/or employees of a commercial interest with business lines or products relating to the content of the CME activity will not be permitted to participate in the planning or execution of any accredited activity.

 

A complete listing of disclosures for all those involved in developing and influencing the content of this activity is below.

Faculty Disclosures

Last Name

Role in Activity

Commercial Interest

Nature of Relevant Relationship

What Was Received

Nature of Relevant Relationship

For What Role

Alshawabkeh

Speaker

  • None
  • N/A
  • N/A

Fan

Speaker

  • None
  • N/A
  • N/A

Heywood

Course Director, Moderator, Speaker

  • Actelion Pharmaceuticals, Pfizer
  • Actelion Pharmaceuticals
  • Honorarium
  • Honorarium
  • Speaker
  • Consultant

Keating

Speaker

  • None
  • N/A
  • N/A

Mohan

Speaker

  • None
  • N/A
  • N/A

Papamatheakis

Speaker

  • Actelion Pharmaceuticals
  • Honorarium
  • Consultant

Shen

Peer Reviewer

  • None
  • N/A
  • N/A

CME Committee

Review and approve CME content

  • None
  • N/A
  • N/A

Scripps Conference Services & CME

Plan, manage, implement, and reconcile activity

  • None
  • N/A
  • N/A

Accreditation and Conflict of Interest Mitigation

Physicians

Scripps Health is accredited by the ACCME to provide continuing medical education for physicians.

 

Scripps Health designates this internet enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Nurses and Nurse Practitioners

For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credit(s)™ issued by organizations accredited by the ACCME.

 

For the purpose of re-licensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credit(s)™ for attendance at structured learning activities offered by organizations accredited by the ACCME.

 

The American Academy of Nurse Practitioners Certified Program (AANPCP) and the American Association of Nurse Practitioners (AANP) accept AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.


Physician Assistants

PAs may claim a maximum of 4 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

 

Conflict of Interest (COI) Mitigation

All relevant financial relationships with ineligible companies listed for individuals in control of content have been mitigated using a multi-step process including independent peer review of presentations.

Event details

Content Available

Wed, Apr 07, 2021 - Thu, Oct 07, 2021

Duration
4 hours
Fee
$35.00